Antihemophilic Factor (Recombinant [Pegylated]) and Gemtuzumab ozogamicin
Determining the interaction of Antihemophilic Factor (Recombinant [Pegylated]) and Gemtuzumab ozogamicin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: gemtuzumab
Brand name: Mylotarg
Synonyms: Gemtuzumab Ozogamicin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Pegylated])-Gemzar
- Antihemophilic Factor (Recombinant [Pegylated])-Gen-Amoxicillin
- Antihemophilic Factor (Recombinant [Pegylated])-Gen-Amoxicillin Oral
- Antihemophilic Factor (Recombinant [Pegylated])-Gen-Budesonide Aq
- Antihemophilic Factor (Recombinant [Pegylated])-Gen-Minoxidol Topical
- Antihemophilic Factor (Recombinant [Pegylated])-Gen-Nitro
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant) (Advate)
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant) (Afstyla)
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant) (Helixate FS and Kogenate FS)
- Gemtuzumab ozogamicin-Antihemophilic Factor (Recombinant) (Kovaltry and Novoeight)